ClearBridge International Growth ADR Strategy exits Linde, adds Roche in Q4 2025
Source: SeekingAlpha
2026-02-04 13:32:33 ET
More on related tickers
- Trane Technologies: Upgrade To Buy On Cheaper Valuation And Better Fundamentals
- Roche Holding AG (RHHBY) Q4 2025 Earnings Call Transcript
- Linde Q4 2025 Earnings Preview
- Genentech in up to $1.7B RNAi licensing deal with SanegeneBio
Read the full article on Seeking Alpha
For further details see:
ClearBridge International Growth ADR Strategy exits Linde, adds Roche in Q4 2025
HEIDELBERG MATERIALS AG
NASDAQ: HDLMY
HDLMY Trading
3.85% G/L:
$39.70 Last:
4,342 Volume:
$39.91 Open:
